SiNtx Technologies Inc (SINT) Actualités

Form S-3 - Registration statement under Securities Act of 1933

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

SINTX Technologies Announces Publication of Study Confirming Superior Performance of Silicon Nitride in Cervical Spine Fusion

SALT LAKE CITY, Utah, March 19, 2025 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or...

Sintx Technologies Announces Board Chairman Transition

SALT LAKE CITY, Utah, March 17, 2025 (GLOBE NEWSWIRE) -- Sintx Technologies, Inc. (NASDAQ: SINT) (“Sintx” or...

Form 8-K - Current report

Form 144 - Report of proposed sale of securities

Form 8-K - Current report

SINTX Technologies Announces $5 Million Private Placement Priced At-the-Market under Nasdaq Rules

Salt Lake City, Utah, Feb. 26, 2025 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc., (“SINTX” or the “Company”...

SINTX Technologies Sells Technology Assesment and Transfer Subsidiary to Focus on Medical Device Market

Strategic Transaction Enhances Financial Flexibility and Supports Growth in Healthcare Innovations Salt Lake...

Form 8-K - Current report

SINTX Receives Issuance of U.S. Patent for Silicon Nitride-Functionalized Zirconia-Toughened Alumina Ceramic Biomaterial

Salt Lake City, Utah, Feb. 19, 2025 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or...

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Form 8-K - Current report

SINTX Technologies Secures Patent Allowance for Wide-Ranging Silicon Nitride Biomaterial Applications

Salt Lake City, Utah, Dec. 17, 2024 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or...